Loading clinical trials...
Loading clinical trials...
This first-in-human study is designed to establish the safety and tolerability of ATR-101 in patients with advanced adrenocortical carcinoma whose tumor has progressed on standard therapy. Information...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Millendo Therapeutics, Inc.
NCT07567456 · Haemodialysis Patients, Blockage of Tunnelled Central Venous Access Device, and more
NCT05644522 · Cerebrovascular Accident, Post-polio Syndrome, and more
NCT06620432 · Placenta Accreta Spectrum
NCT07244458 · Dietary Change, Obesity & Overweight, and more
NCT07129590 · Smoking Cessation, Tobacco Smoking, and more
Moffitt Cancer Center
Tampa, Florida
National Institutes of Health/National Cancer Institute
Bethesda, Maryland
University of Michigan Cancer Center
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions